[1]
Cherif H. and Karlsson T. 2014. Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia. Upsala Journal of Medical Sciences. 119, 4 (Sep. 2014), 350–353. DOI:https://doi.org/10.3109/03009734.2014.955619.